Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 7 of 7)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
23-Nov-09 Reuters Investment Profile N/A Northwest Biotherapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
7-Nov-09 Wright Reports N/A Wright Investors Service Comprehensive Report for Northwest Biotherapeutics, Inc. 42 $65 View Abstract
5-Nov-09 Global Markets Direct Global Markets Direct Northwest Biotherapeutics, Inc. - medical equipment - Deals and Alliances Profile 15 $250 View Abstract
4-Nov-09 Global Markets Direct Global Markets Direct Northwest Biotherapeutics, Inc. Financial and Strategic Analysis Review 19 $300 View Abstract
29-Mar-09 PriceTarget Research, Inc. N/A Drug Intelligence Monitor: overall outlook VERY STRONG - 25 new Leaders; 10 new Laggards. 50 $20 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala NORTHWEST BIOTHERAPEUTICS INC (NWBO=US) 12-months forecast 1 $15 View Abstract
28-Mar-09 Pechala's Reports Lubomir Pechala NORTHWEST BIOTHERAPEUTICS INC (NWBO=US) 2-weeks forecast 1 $10 View Abstract

Independent Reports (Showing 1 to 7 of 7)

Release
Date Contributor Author Title Pages Price More Info
23-Nov-09 Reuters Investment Profile N/A Northwest Biotherapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
7-Nov-09 Wright Reports N/A Wright Investors Service Comprehensive Report for Northwest Biotherapeutics, Inc. 42 $65 View Abstract
5-Nov-09 Global Markets Direct Global Markets Direct Northwest Biotherapeutics, Inc. - medical equipment - Deals and Alliances Profile 15 $250 View Abstract
4-Nov-09 Global Markets Direct Global Markets Direct Northwest Biotherapeutics, Inc. Financial and Strategic Analysis Review 19 $300 View Abstract
29-Mar-09 PriceTarget Research, Inc. N/A Drug Intelligence Monitor: overall outlook VERY STRONG - 25 new Leaders; 10 new Laggards. 50 $20 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala NORTHWEST BIOTHERAPEUTICS INC (NWBO=US) 12-months forecast 1 $15 View Abstract
28-Mar-09 Pechala's Reports Lubomir Pechala NORTHWEST BIOTHERAPEUTICS INC (NWBO=US) 2-weeks forecast 1 $10 View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.